AINMF (NetraMark Holdings) EBIT: $-4.65 Mil (TTM As of Mar. 2026)


AINMF NetraMark Holdings Inc AINMF
22 GF Score
Price $0.42
GF Value $0.21
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is NetraMark Holdings EBIT?

NetraMark Holdings AINMF -4.35% 22 EBIT is $-4.65 Mil as of Mar. 2026. GuruFocus rates AINMF with a GF Score™ of 22/100 and a GF Value™ of $0.21 (Significantly Overvalued). The stock has 2 warning signs investors should review.

NetraMark Holdings's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was $-1.59 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $-4.65 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. NetraMark Holdings's annualized ROC % for the quarter that ended in Mar. 2026 was -63,720.00%. NetraMark Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was %.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. NetraMark Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -12.09%.

NetraMark Holdings  (OTCPK:AINMF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

NetraMark Holdings's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-6.372 * ( 1 - 0% )/( (0.01 + 0.0099999999999998)/ 2 )
=-6.372/0.0099999999999999
=-63,720.00 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1.116 - 0.247 - ( 1.021 - max(0, 0.257 - 1.116+1.021))
=0.01

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2.837 - 0.519 - ( 2.706 - max(0, 0.529 - 2.837+2.706))
=0.0099999999999998

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

NetraMark Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-6.372/( ( (0 + max(-0.239, 0)) + (0 + max(-0.463, 0)) )/ 2 )
=-6.372/( ( 0 + 0 )/ 2 )
=-6.372/0
= %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.018) - (0.247 + 0.009 + 0.001)
=-0.239

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.046 + 0 + 0.02) - (0.519 + 0.009 + 0.001)
=-0.463

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

NetraMark Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=-4.653/38.492
=-12.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NetraMark Holdings EBIT Related Terms

NetraMark Holdings EBIT Historical Data

* Premium members only.

The historical data trend for NetraMark Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NetraMark Holdings EBIT Chart

NetraMark Holdings Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
EBIT
Get a 7-Day Free Trial -3.98 -5.95 -4.33 -2.46 -3.77

NetraMark Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.11 -1.00 -1.11 -0.95 -1.59

AINMF vs VEEV, BTSG, TEM: EBIT Comparison

For the Health Information Services subindustry, NetraMark Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NetraMark Holdings EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NetraMark Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where NetraMark Holdings's EV-to-EBIT falls into.


AINMF
22GF Score
NetraMark Holdings Inc AINMF
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NetraMark Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-4.65 Mil mean?
NetraMark Holdings (AINMF) has a EBIT of $-4.65 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on NetraMark Holdings.
Is NetraMark Holdings' EBIT too high?
NetraMark Holdings' current EBIT is $-4.65 Mil. Overall, NetraMark Holdings has a GF Score™ of 22/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NetraMark Holdings' EBIT compare to VEEV and BTSG?
NetraMark Holdings' EBIT of $-4.65 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on NetraMark Holdings. NetraMark Holdings's current EBIT is $-4.65 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NetraMark Holdings stock overvalued right now?
Based on GuruFocus' analysis, NetraMark Holdings (AINMF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.21, compared to a current price of $0.42 — trading 100.2% above its estimated fair value. The current EBIT is $-4.65 Mil. NetraMark Holdings' overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For NetraMark Holdings (AINMF), the current EBIT is $-4.65 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NetraMark Holdings (AINMF) Overvalued in 2026?

Based on GuruFocus' analysis, NetraMark Holdings stock appears to be overvalued. The current stock price of $0.42 is trading 100.2% above its estimated GF Value™ of $0.21. GuruFocus considers NetraMark Holdings to be Significantly Overvalued.

Key valuation signals for AINMF:

  • EBIT: $-4.65 Mil
  • GF Value™: $0.21 vs. price of $0.42 (100.2% above fair value)
  • GF Score™: 22/100 with 2 warning signs

No single metric tells the full story. See the AINMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NetraMark Holdings Business Description

Other Exchanges PF0:GermanyAIAI:Canada
Address 1655 Dupont Street, Suite 101, Toronto, ON, CAN, M6P 3T1
NetraMark Holdings Inc provides AI-powered insights and software solutions to optimize clinical trial design and outcomes for pharmaceutical sponsors. The company offers AI solutions to trial sponsors, CROs, and biotechnology companies across the globe. It earns revenue from its proprietary NetraAI platform, an advanced machine learning system purpose-built to analyze complex clinical trial data and identify meaningful patient subpopulations.
22GF Score

Get the complete analysis for AINMF

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.42
Price
$0.21
GF Value